Jundishapur Journal of Health Sciences

Published by: Kowsar

Isobologram Curve of Leishmanicidal Effects of Amiodarone and Ketoconazole

Somayeh Bahrami 1 , * , Mohammad Hossein Razi Jalali 1 , Hossein Najafzadeh 2 and Zeinab Asadi 1
Authors Information
1 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran
2 Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran
Article information
  • Jundishapur Journal of Health Sciences (JJHS): October 2017, 9 (4); e57990
  • Published Online: July 26, 2017
  • Article Type: Research Article
  • Received: October 10, 2016
  • Revised: December 5, 2016
  • Accepted: February 4, 2017
  • DOI: 10.5812/jjhs.57990

To Cite: Bahrami S, Razi Jalali M H, Najafzadeh H, Asadi Z. Isobologram Curve of Leishmanicidal Effects of Amiodarone and Ketoconazole, Jundishapur J Health Sci. 2017 ;9(4):e57990. doi: 10.5812/jjhs.57990.

Abstract
Copyright: Copyright © 2017, Jundishapur Journal of Health Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005; 366(9496): 1561-77[DOI][PubMed]
  • 2. Simonsen PE, Cook GC, Zumla AI. Manson's tropical diseases. 2009;
  • 3. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc. 2001; 6(3): 175-82[DOI][PubMed]
  • 4. Saki J, Meamar A, Oormazdi H, Akhlaghi L, Maraghi S, Mohebali M, et al. Mini-exon genotyping of leishmania species in khuzestan province, southwest iran. Iran J Parasitol. 2010; 5(1): 25-34[PubMed]
  • 5. Saki J, Khademvatan S. A molecular study on cutaneous leishmaniasis lesions in Khuzestan province (South west of Iran). Jundishapur J Microbiol. 2011; 4(4): 283-8
  • 6. Alborzi A, Rasouli M, Shamsizadeh A. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg. 2006; 74(2): 306-7[PubMed]
  • 7. Mohebali M, Hajjaran H, Hamzavi Y, Mobedi I, Arshi S, Zarei Z, et al. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet Parasitol. 2005; 129(3-4): 243-51[DOI][PubMed]
  • 8. Di Giorgio C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol. 2004; 106(3-4): 67-74[DOI][PubMed]
  • 9. Rosenthal E, Marty P. Recent understanding in the treatment of visceral leishmaniasis. J Postgrad Med. 2003; 49(1): 61-8[PubMed]
  • 10. Savoia D. Recent updates and perspectives on leishmaniasis. J Infect Dev Ctries. 2015; 9(6): 588-96[DOI][PubMed]
  • 11. Korashy HM, Shayeganpour A, Brocks DR, El-Kadi AO. Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicol Sci. 2007; 97(1): 32-43[DOI][PubMed]
  • 12. Benaim G, Sanders JM, Garcia-Marchan Y, Colina C, Lira R, Caldera AR, et al. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem. 2006; 49(3): 892-9[DOI][PubMed]
  • 13. Serrano-Martin X, Garcia-Marchan Y, Fernandez A, Rodriguez N, Rojas H, Visbal G, et al. Amiodarone destabilizes intracellular Ca2+ homeostasis and biosynthesis of sterols in Leishmania mexicana. Antimicrob Agents Chemother. 2009; 53(4): 1403-10[DOI][PubMed]
  • 14. de Macedo-Silva ST, de Oliveira Silva TL, Urbina JA, de Souza W, Rodrigues JC. Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis. Mol Biol Int. 2011; 2011: 876021[DOI][PubMed]
  • 15. Bahrami S, Hatam GR, Razavi M, Nazifi S. In vitro cultivation of axenic amastigotes and the comparison of antioxidant enzymes at different stages of Leishmania tropica. Trop Biomed. 2011; 28(2): 411-7[PubMed]
  • 16. Gupta N, Goyal N, Rastogi AK. In vitro cultivation and characterization of axenic amastigotes of Leishmania. Trends Parasitol. 2001; 17(3): 150-3[DOI][PubMed]
  • 17. Hallander HO, Dornbusch K, Gezelius L, Jacobson K, Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother. 1982; 22(5): 743-52[DOI][PubMed]
  • 18. Reimao JQ, Tempone AG. Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs. Mem Inst Oswaldo Cruz. 2011; 106(8): 1032-8[DOI][PubMed]
  • 19. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RJ, Magill AJ, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis. 1998; 27(6): 1457-64[DOI][PubMed]
  • 20. Domingo P, Ferrer S, Kolle L, Munoz C, Rodriguez P. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus. Arch Intern Med. 1996; 156(9): 1029[DOI][PubMed]
  • 21. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006; 19(1): 111-26[DOI][PubMed]
  • 22. Sindermann H, Croft SL, Engel KR, Bommer W, Eibl HJ, Unger C, et al. Miltefosine (Impavido): the first oral treatment against leishmaniasis. Med Microbiol Immunol. 2004; 193(4): 173-80[DOI][PubMed]
  • 23. Ganguly NK. Oral miltefosine may revolutionize treatment of visceral leishmaniasis. TDR news. 2002; 68(2)
  • 24. van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. Combination therapy for visceral leishmaniasis. Lancet Infect Dis. 2010; 10(3): 184-94[DOI][PubMed]
  • 25. de Souza W, Sant'Anna C, Cunha-e-Silva NL. Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa. Prog Histochem Cytochem. 2009; 44(2): 67-124[DOI][PubMed]
  • 26. Soares MJ, de Souza W. Endocytosis of gold-labeled proteins and LDL by Trypanosoma cruzi. Parasitol Res. 1991; 77(6): 461-8[DOI][PubMed]
  • 27. Urbina JA. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology. 1997; 114 Suppl-9[PubMed]
  • 28. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol. 2003; 126(2): 129-42[DOI][PubMed]
  • 29. Serrano-Martin X, Payares G, De Lucca M, Martinez JC, Mendoza-Leon A, Benaim G. Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis. Antimicrob Agents Chemother. 2009; 53(12): 5108-13[DOI][PubMed]
  • 30. Courchesne WE. Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. J Pharmacol Exp Ther. 2002; 300(1): 195-9[DOI][PubMed]
  • 31. Gupta SS, Ton VK, Beaudry V, Rulli S, Cunningham K, Rao R. Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. J Biol Chem. 2003; 278(31): 28831-9[DOI][PubMed]
  • 32. Pozniakovsky AI, Knorre DA, Markova OV, Hyman AA, Skulachev VP, Severin FF. Role of mitochondria in the pheromone- and amiodarone-induced programmed death of yeast. J Cell Biol. 2005; 168(2): 257-69[DOI][PubMed]
  • 33. Veiga-Santos P, Barrias ES, Santos JF, de Barros Moreira TL, de Carvalho TM, Urbina JA, et al. Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents. 2012; 40(1): 61-71[DOI][PubMed]
  • 34. Pirson P, Leclef B, Trouet A. Activity of ketoconazole derivatives against Leishmania mexicana amazonensis within mouse peritoneal macrophages. Ann Trop Med Parasitol. 1990; 84(2): 133-9[DOI][PubMed]
  • 35. Lazardi K, Urbina JA, de Souza W. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother. 1990; 34(11): 2097-105[DOI][PubMed]
  • 36. Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009; 16(2-3): 97-110[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader